-
Published10/04/2024
-
Deadline13/05/2024
-
Today18/08/2026
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
CONCLUSION OF A FRAMEWORK AGREEMENT FOR THE SUPPLY OF PEGFILGRASTIM OR LIPEGFILGRASTIM 6 MG/0.6 ML (INJECTABLE) FOR ADULT PATIENTS FOR A PERIOD OF TWO YEARS RENEWABLE TWICE FOR A DURATION OF ONE YEAR
CONCLUSION OF A FRAMEWORK AGREEMENT FOR THE SUPPLY OF PEGFILGRASTIM OR LIPEGFILGRASTIM 6 MG/0.6 ML (INJECTABLE) FOR ADULT PATIENTS FOR A PERIOD OF TWO YEARS RENEWABLE TWICE FOR A DURATION OF ONE YEAR
https://www.publicprocurement.be/supplier/enterprises/0/tendering-workspaces/publication-workspace-detail/19d7a620-254a-448f-bf41-840898e467c1/general
https://www.publicprocurement.be/supplier/enterprises/0/tendering-workspaces/publication-workspace-detail/19d7a620-254a-448f-bf41-840898e467c1/general
33000000 - Medical equipments, pharmaceuticals and personal care products
33600000 - Pharmaceutical products
Type: price
Description: Le pouvoir adjudicateur choisira, pour attribuer le présent marché public, le soumissionnaire ayant déposé l’offre économiquement la plus avantageuse sur base du montant total annuel net TVAC (soit le prix d’achat indiqué dans l’Annexe B. Inventaire, point 10) en tenant compte de la formule suivante : Pondération = [montant total annuel net TVAC le plus bas/montant total annuel net TVAC de l’offre analysée] * 100
Weight (percentage, exact):
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.